Taking it up a notch: a promising immunotherapy against small cell lung cancer

Transl Lung Cancer Res. 2023 May 31;12(5):948-952. doi: 10.21037/tlcr-23-230. Epub 2023 Apr 26.

Authors

Alanisse A Apaydin^{1

2}, Julien Sage^{1

2}

Affiliations

¹ Department of Pediatrics, Stanford University, Stanford, CA, USA.
² Department of Genetics, Stanford University, Stanford, CA, USA.

No abstract available

Keywords: Small cell lung cancer (SCLC); Tarlatamab; delta-like ligand 3 (DLL3); immunotherapy.

Publication types

Editorial

Grants and funding

R35 CA231997/CA/NCI NIH HHS/United States